Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For Trade and Medical Media Only Trial met FDA and EMA-pre-specified primary endpoints versus daily standard of care Data to support global regulatory filings in mid-2022 Cidara to host investor
Salt Lake City, Utah--(Newsfile Corp. - December 14, 2021) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced topline data from its vehicle-controlled, randomized safety
York getting strong winds. this is topline, north end of the front pulling through, it won't be until late tonight until we're out of the woods in boston and rhode island. this is a serious storm system, already historic. december is not known for severe weather but this is going down in the history books likely the most deadly and perhaps most damaging tornado outbreak we've ever seen in december. a lot to come on this but state heads up, if you get warnings tonight, take action. griff: quickly, amy, the amount of time the tornadoes may have spent on the ground part of the historic content. >...
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209006035/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma
Ad hoc announcement pursuant to Art. 53 LR Vamorolone given throughout the study showed sustained efficacy across multiple endpoints over 48 weeks and the good safety and tolerability profile